• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫疟疾中配子体杀灭药物治疗反应的评估

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.

作者信息

White Nicholas J, Ashley Elizabeth A, Recht Judith, Delves Michael J, Ruecker Andrea, Smithuis Frank M, Eziefula Alice C, Bousema Teun, Drakeley Chris, Chotivanich Kesinee, Imwong Mallika, Pukrittayakamee Sasithon, Prachumsri Jetsumon, Chu Cindy, Andolina Chiara, Bancone Germana, Hien Tran T, Mayxay Mayfong, Taylor Walter R J, von Seidlein Lorenz, Price Ric N, Barnes Karen I, Djimdé Abdoulaye, ter Kuile Feiko, Gosling Roly, Chen Ingrid, Dhorda Mehul J, Stepniewska Kasia, Guérin Philippe, Woodrow Charles J, Dondorp Arjen M, Day Nicholas P J, Nosten Francois H

机构信息

Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Malar J. 2014 Dec 9;13:483. doi: 10.1186/1475-2875-13-483.

DOI:10.1186/1475-2875-13-483
PMID:25486998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4295364/
Abstract

Indirect clinical measures assessing anti-malarial drug transmission-blocking activity in falciparum malaria include measurement of the duration of gametocytaemia, the rate of gametocyte clearance or the area under the gametocytaemia-time curve (AUC). These may provide useful comparative information, but they underestimate dose-response relationships for transmission-blocking activity. Following 8-aminoquinoline administration P. falciparum gametocytes are sterilized within hours, whereas clearance from blood takes days. Gametocytaemia AUC and clearance times are determined predominantly by the more numerous female gametocytes, which are generally less drug sensitive than the minority male gametocytes, whereas transmission-blocking activity and thus infectivity is determined by the more sensitive male forms. In choosing doses of transmission-blocking drugs there is no substitute yet for mosquito-feeding studies.

摘要

评估恶性疟原虫中抗疟药物传播阻断活性的间接临床指标包括测量配子体血症持续时间、配子体清除率或配子体血症-时间曲线下面积(AUC)。这些指标可能提供有用的比较信息,但它们低估了传播阻断活性的剂量-反应关系。给予8-氨基喹啉后,恶性疟原虫配子体在数小时内被灭活,而从血液中清除则需要数天。配子体血症AUC和清除时间主要由数量较多的雌配子体决定,雌配子体通常比少数雄配子体对药物更不敏感,而传播阻断活性以及由此产生的传染性则由更敏感的雄配子体形式决定。在选择传播阻断药物剂量时,目前尚无替代蚊虫叮咬研究的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/ca4dc7733c5d/12936_2014_3664_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/43c46e2dd01a/12936_2014_3664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/42f8e1c1c096/12936_2014_3664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/fcd1cf84edfc/12936_2014_3664_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/f295debfb58f/12936_2014_3664_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/87a51ae9c886/12936_2014_3664_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/d9e7ab62f23e/12936_2014_3664_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/a2bd70452edd/12936_2014_3664_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/35317d1382fd/12936_2014_3664_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/f65c649b6a5c/12936_2014_3664_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/ca4dc7733c5d/12936_2014_3664_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/43c46e2dd01a/12936_2014_3664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/42f8e1c1c096/12936_2014_3664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/fcd1cf84edfc/12936_2014_3664_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/f295debfb58f/12936_2014_3664_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/87a51ae9c886/12936_2014_3664_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/d9e7ab62f23e/12936_2014_3664_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/a2bd70452edd/12936_2014_3664_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/35317d1382fd/12936_2014_3664_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/f65c649b6a5c/12936_2014_3664_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0540/4295364/ca4dc7733c5d/12936_2014_3664_Fig10_HTML.jpg

相似文献

1
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.恶性疟原虫疟疾中配子体杀灭药物治疗反应的评估
Malar J. 2014 Dec 9;13:483. doi: 10.1186/1475-2875-13-483.
2
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.伯氨喹或其他8-氨基喹啉用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2015 Feb 19(2):CD008152. doi: 10.1002/14651858.CD008152.pub4.
3
A randomized feasibility trial comparing four antimalarial drug regimens to induce gametocytemia in the controlled human malaria infection model.一项比较四种抗疟药物方案诱导人体疟疾感染模型配子体血症的随机可行性试验。
Elife. 2018 Feb 27;7:e31549. doi: 10.7554/eLife.31549.
4
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.伯氨喹或其他8-氨基喹啉用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2014 Jun 30(6):CD008152. doi: 10.1002/14651858.CD008152.pub3.
5
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.尼日利亚儿童中的恶性疟原虫配子体血症:抗疟药物治疗前、治疗期间及治疗后情况
Trop Med Int Health. 2003 Sep;8(9):783-92. doi: 10.1046/j.1365-3156.2003.01093.x.
6
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations.优化磷酸氯喹治疗时机以降低低流行区泰缅边境人群中疟原虫传播。
Malar J. 2009 Jul 15;8:159. doi: 10.1186/1475-2875-8-159.
7
Gametocyte carriage in Plasmodium falciparum-infected travellers.恶性疟原虫感染旅行者中的配子体携带。
Malar J. 2013 Jan 24;12:31. doi: 10.1186/1475-2875-12-31.
8
Plasmodium falciparum gametocytaemia with chloroquine chemotherapy in persistent malaria in an endemic area of India.印度某疟疾流行地区持续性疟疾中氯喹化疗对恶性疟原虫配子体血症的影响
Indian J Med Res. 2009 Mar;129(3):299-304.
9
DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with .DSM265 在 400 毫克时可清除健康受感染对象血液中的无性阶段寄生虫,但不能清除成熟配子。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.01837-18. Print 2019 Apr.
10
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.肯尼亚儿童接受磺胺多辛-乙胺嘧啶单药治疗或与青蒿琥酯联合治疗后(亚)显微镜下恶性疟原虫配子体血症情况
Int J Parasitol. 2006 Apr;36(4):403-8. doi: 10.1016/j.ijpara.2006.01.002. Epub 2006 Jan 24.

引用本文的文献

1
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data.青蒿素联合疗法、非青蒿素疗法及8-氨基喹啉抗疟疗法的传播阻断活性:个体参与者数据的汇总分析
PLoS Med. 2025 Aug 14;22(8):e1004683. doi: 10.1371/journal.pmed.1004683. eCollection 2025 Aug.
2
An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.一种用于恶性疟原虫疟疾传播阻断药物体外发现和体内测试的一体化流程。
Nat Commun. 2025 Jul 25;16(1):6884. doi: 10.1038/s41467-025-62014-3.
3

本文引用的文献

1
Quantification of female and male Plasmodium falciparum gametocytes by reverse transcriptase quantitative PCR.通过逆转录定量PCR对恶性疟原虫雌、雄配子体进行定量分析。
Mol Biochem Parasitol. 2015 Jan-Feb;199(1-2):29-33. doi: 10.1016/j.molbiopara.2015.03.006. Epub 2015 Mar 28.
2
Primaquine: the risks and the benefits.伯氨喹:风险与益处
Malar J. 2014 Nov 3;13:418. doi: 10.1186/1475-2875-13-418.
3
A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.
Post-treatment transmissibility of Plasmodium falciparum infections: an observational cohort study.
恶性疟原虫感染治疗后的传播性:一项观察性队列研究。
Malar J. 2025 Mar 17;24(1):87. doi: 10.1186/s12936-025-05279-9.
4
Transmission-blocking activities of artesunate, chloroquine, and methylene blue on gametocytes.青蒿琥酯、氯喹和亚甲蓝对配子体的阻断作用。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0085324. doi: 10.1128/aac.00853-24. Epub 2024 Jul 26.
5
The assessment of antimalarial drug efficacy in vivo.体内抗疟药物功效评估。
Trends Parasitol. 2022 Aug;38(8):660-672. doi: 10.1016/j.pt.2022.05.008. Epub 2022 Jun 6.
6
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.单剂量磷酸萘酚喹联合双氢青蒿素哌喹降低马里乌莱塞布古的疟原虫传播:一项 2 期、单盲、随机临床试验。
Lancet Microbe. 2022 May;3(5):e336-e347. doi: 10.1016/S2666-5247(21)00356-6. Epub 2022 Mar 23.
7
A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania.在坦桑尼亚巴加莫约地区,单次低剂量的伯氨喹足以安全且充分地减少恶性疟原虫配子体的传播,而无论细胞色素 P450 2D6 酶的活性如何。
Malar J. 2022 Mar 12;21(1):84. doi: 10.1186/s12936-022-04100-1.
8
Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial.甲氟喹-青蒿琥酯或双氢青蒿素-哌喹联合单低剂量伯氨喹预防马里乌埃勒塞布布戈疟疾传播:一项四臂、单盲、2/3 期、随机试验。
Lancet Microbe. 2022 Jan;3(1):e41-e51. doi: 10.1016/S2666-5247(21)00192-0.
9
Assessment of the Antimalarial and Transmission-Blocking Activities of Cipargamin and Ganaplacide in Artemisinin-Resistant .评估青蒿素耐药疟原虫中西泊酰胺和加那帕利的抗疟和阻断传播活性。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0148121. doi: 10.1128/AAC.01481-21. Epub 2022 Jan 3.
10
The prevention and treatment of Plasmodium vivax malaria.疟原虫 vivax 疟疾的预防和治疗。
PLoS Med. 2021 Apr 23;18(4):e1003561. doi: 10.1371/journal.pmed.1003561. eCollection 2021 Apr.
一种用于鉴定具有生物学相关性的疟疾传播阻断药物的雌雄配子体功能活力测定法。
Antimicrob Agents Chemother. 2014 Dec;58(12):7292-302. doi: 10.1128/AAC.03666-14. Epub 2014 Sep 29.
4
Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biology.恶性疟原虫V期配子体蛋白质组的性别分区为深入了解恶性疟原虫特有的细胞生物学提供了线索。
Mol Cell Proteomics. 2014 Oct;13(10):2705-24. doi: 10.1074/mcp.M114.040956. Epub 2014 Jul 23.
5
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.伯氨喹或其他8-氨基喹啉用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2014 Jun 30(6):CD008152. doi: 10.1002/14651858.CD008152.pub3.
6
Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.单次剂量磷酸萘酚喹清除乌干达无并发症疟疾儿童疟原虫配子体:一项随机、对照、双盲、剂量范围试验。
Lancet Infect Dis. 2014 Feb;14(2):130-9. doi: 10.1016/S1473-3099(13)70268-8. Epub 2013 Nov 13.
7
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.伯氨喹向其活性代谢物的代谢取决于细胞色素P450 2D6。
Malar J. 2013 Jun 20;12:212. doi: 10.1186/1475-2875-12-212.
8
Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection.根据恶性疟原虫配子体密度预测蚊虫感染情况并估计感染源。
Elife. 2013 May 21;2:e00626. doi: 10.7554/eLife.00626.
9
Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.雄性和雌性疟原虫成熟配子体对抗疟药物表现出不同的反应。
Antimicrob Agents Chemother. 2013 Jul;57(7):3268-74. doi: 10.1128/AAC.00325-13. Epub 2013 Apr 29.
10
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.推荐较低剂量的伯氨喹啉作为常见 G6PD 缺乏地区疟原虫配子体杀灭剂的理由。
Malar J. 2012 Dec 14;11:418. doi: 10.1186/1475-2875-11-418.